Beefing up Prostate Cancer Therapy with Performance-Enhancing (Anti-) Steroids

William G. Nelson; Michael Haffner; Srinivasan Yegnasubramanian

doi:10.1016/j.ccr.2011.06.019

Beefing up Prostate Cancer Therapy with Performance-Enhancing (Anti-) Steroids

William G. Nelson, Michael Haffner, Srinivasan Yegnasubramanian

School of Medicine

Research output: Contribution to journal › Short survey › peer-review

4 Scopus citations

Abstract

In the May 26th issue of the New England Journal of Medicine, de Bono et al. report that the inhibition of androgen synthesis by abiraterone acetate prolonged the survival of men with prostate cancer previously treated by androgen suppression.

Original language	English (US)
Pages (from-to)	7-9
Number of pages	3
Journal	Cancer cell
Volume	20
Issue number	1
DOIs	https://doi.org/10.1016/j.ccr.2011.06.019
State	Published - Jul 12 2011

ASJC Scopus subject areas

Oncology
Cell Biology
Cancer Research

Access to Document

10.1016/j.ccr.2011.06.019

Cite this

@article{1ca98984f7ec427cb375064dcf11591a,

title = "Beefing up Prostate Cancer Therapy with Performance-Enhancing (Anti-) Steroids",

abstract = "In the May 26th issue of the New England Journal of Medicine, de Bono et al. report that the inhibition of androgen synthesis by abiraterone acetate prolonged the survival of men with prostate cancer previously treated by androgen suppression.",

author = "Nelson, {William G.} and Michael Haffner and Srinivasan Yegnasubramanian",

year = "2011",

month = jul,

day = "12",

doi = "10.1016/j.ccr.2011.06.019",

language = "English (US)",

volume = "20",

pages = "7--9",

journal = "Cancer cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "1",

}

TY - JOUR

T1 - Beefing up Prostate Cancer Therapy with Performance-Enhancing (Anti-) Steroids

AU - Nelson, William G.

AU - Haffner, Michael

AU - Yegnasubramanian, Srinivasan

PY - 2011/7/12

Y1 - 2011/7/12

N2 - In the May 26th issue of the New England Journal of Medicine, de Bono et al. report that the inhibition of androgen synthesis by abiraterone acetate prolonged the survival of men with prostate cancer previously treated by androgen suppression.

AB - In the May 26th issue of the New England Journal of Medicine, de Bono et al. report that the inhibition of androgen synthesis by abiraterone acetate prolonged the survival of men with prostate cancer previously treated by androgen suppression.

UR - http://www.scopus.com/inward/record.url?scp=79960074439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960074439&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2011.06.019

DO - 10.1016/j.ccr.2011.06.019

M3 - Short survey

C2 - 21741594

AN - SCOPUS:79960074439

SN - 1535-6108

VL - 20

SP - 7

EP - 9

JO - Cancer cell

JF - Cancer cell

IS - 1

ER -

Beefing up Prostate Cancer Therapy with Performance-Enhancing (Anti-) Steroids

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this